The promising combination therapy strategy for overcoming resistance to histone deacetylase inhibitors in diffuse large B‐cell lymphoma
Abstract Single histone deacetylases inhibitors (HDACis) or current combination therapies show limited clinical efficiency in facing the striking heterogeneity of diffuse large B‐cell lymphoma (DLBCL). This commentary reviews the research conducted by Wang et al. to demonstrate the mechanism of the...
Sparad:
| Huvudskapare: | , |
|---|---|
| Materialtyp: | Bok |
| Publicerad: |
Wiley,
2022-06-01T00:00:00Z.
|
| Ämnen: | |
| Länkar: | Connect to this object online. |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|
Internet
Connect to this object online.3rd Floor Main Library
| Signum: |
A1234.567 |
|---|---|
| Exemplar 1 | Tillgänglig |